A Pathway from Chromosome Transfer to Engineering Resulting in Human and Mouse Artificial Chromosomes for a Variety of Applications to Bio-medical Challenges

Overview

Journal Chromosome Res

Date 2015 Feb 7

PMID 25657031

Citations 44

Authors

Mitsuo Oshimura

Narumi Uno

Yasuhiro Kazuki

Motonobu Katoh

Toshiaki Inoue

Affiliations

Soon will be listed here.

Abstract

Microcell-mediated chromosome transfer (MMCT) is a technique to transfer a chromosome from defined donor cells into recipient cells and to manipulate chromosomes as gene delivery vectors and open a new avenue in somatic cell genetics. However, it is difficult to uncover the function of a single specific gene via the transfer of an entire chromosome or fragment, because each chromosome or fragment contains a set of numerous genes. Thus, alternative tools are human artificial chromosome (HAC) and mouse artificial chromosome (MAC) vectors, which can carry a gene or genes of interest. HACs/MACs have been generated mainly by either a "top-down approach" (engineered creation) or a "bottom-up approach" (de novo creation). HACs/MACs with one or more acceptor sites exhibit several characteristics required by an ideal gene delivery vector, including stable episomal maintenance and the capacity to carry large genomic loci plus their regulatory elements, thus allowing the physiological regulation of the introduced gene in a manner similar to that of native chromosomes. The MMCT technique is also applied for manipulating HACs and MACs in donor cells and delivering them to recipient cells. This review describes the lessons learned and prospects identified from studies on the construction of HACs and MACs, and their ability to drive exogenous gene expression in cultured cells and transgenic animals via MMCT. New avenues for a variety of applications to bio-medical challenges are also proposed.

Citing Articles

Microcell-mediated chromosome transfer between non-identical human iPSCs.

Uno N, Miyamoto H, Yamazaki K, Egawa M, Kobayashi H, Kazuki K Mol Ther Nucleic Acids. 2024; 35(4):102382.

PMID: 39634136 PMC: 11616053. DOI: 10.1016/j.omtn.2024.102382.

Treatment of CHO cells with Taxol and reversine improves micronucleation and microcell-mediated chromosome transfer efficiency.

Uno N, Satofuka H, Miyamoto H, Honma K, Suzuki T, Yamazaki K Mol Ther Nucleic Acids. 2023; 33:391-403.

PMID: 37547291 PMC: 10403731. DOI: 10.1016/j.omtn.2023.07.002.

Modeling Duchenne Muscular Dystrophy Cardiomyopathy with Patients' Induced Pluripotent Stem-Cell-Derived Cardiomyocytes.

Eisen B, Binah O Int J Mol Sci. 2023; 24(10).

PMID: 37240001 PMC: 10218670. DOI: 10.3390/ijms24108657.

Chromosomal instability drives convergent and divergent evolution toward advantageous inherited traits in mammalian CHO bioproduction lineages.

Huhn S, Chang M, Kumar A, Liu R, Jiang B, Betenbaugh M iScience. 2022; 25(4):104074.

PMID: 35355517 PMC: 8958363. DOI: 10.1016/j.isci.2022.104074.

Panel of human cell lines with human/mouse artificial chromosomes.

Uno N, Takata S, Komoto S, Miyamoto H, Nakayama Y, Osaki M Sci Rep. 2022; 12(1):3009.

PMID: 35194085 PMC: 8863800. DOI: 10.1038/s41598-022-06814-3.

References

Fournier R, Ruddle F . Microcell-mediated transfer of murine chromosomes into mouse, Chinese hamster, and human somatic cells. Proc Natl Acad Sci U S A. 1977; 74(1):319-23. PMC: 393251. DOI: 10.1073/pnas.74.1.319. View

Kakeda M, Hiratsuka M, Nagata K, Kuroiwa Y, Kakitani M, Katoh M . Human artificial chromosome (HAC) vector provides long-term therapeutic transgene expression in normal human primary fibroblasts. Gene Ther. 2005; 12(10):852-6. DOI: 10.1038/sj.gt.3302483. View

Tedesco F, Gerli M, Perani L, Benedetti S, Ungaro F, Cassano M . Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy. Sci Transl Med. 2012; 4(140):140ra89. DOI: 10.1126/scitranslmed.3003541. View

Odom G, Gregorevic P, Chamberlain J . Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advances. Biochim Biophys Acta. 2006; 1772(2):243-62. PMC: 1894910. DOI: 10.1016/j.bbadis.2006.09.007. View

Doherty A, Fisher E . Microcell-mediated chromosome transfer (MMCT): small cells with huge potential. Mamm Genome. 2003; 14(9):583-92. DOI: 10.1007/s00335-003-4002-0. View

Voet T, Schoenmakers E, Carpentier S, Labaere C, Marynen P . Controlled transgene dosage and PAC-mediated transgenesis in mice using a chromosomal vector. Genomics. 2003; 82(6):596-605. DOI: 10.1016/s0888-7543(03)00112-5. View

Chen B, Gilbert L, Cimini B, Schnitzbauer J, Zhang W, Li G . Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system. Cell. 2013; 155(7):1479-91. PMC: 3918502. DOI: 10.1016/j.cell.2013.12.001. View

Mejia J, Willmott A, Levy E, Earnshaw W, Larin Z . Functional complementation of a genetic deficiency with human artificial chromosomes. Am J Hum Genet. 2001; 69(2):315-26. PMC: 1235305. DOI: 10.1086/321977. View

Suzuki N, Nishii K, Okazaki T, Ikeno M . Human artificial chromosomes constructed using the bottom-up strategy are stably maintained in mitosis and efficiently transmissible to progeny mice. J Biol Chem. 2006; 281(36):26615-23. DOI: 10.1074/jbc.M603053200. View

10.

Ren X, Katoh M, Hoshiya H, Kurimasa A, Inoue T, Ayabe F . A novel human artificial chromosome vector provides effective cell lineage-specific transgene expression in human mesenchymal stem cells. Stem Cells. 2005; 23(10):1608-16. DOI: 10.1634/stemcells.2005-0021. View

11.

Takahashi Y, Tsuji S, Kazuki Y, Noguchi M, Arifuku I, Umebayashi Y . Development of evaluation system for bioactive substances using human artificial chromosome-mediated osteocalcin gene expression. J Biochem. 2010; 148(1):29-34. DOI: 10.1093/jb/mvq030. View

12.

Nakayama Y, Uno N, Uno K, Mizoguchi Y, Komoto S, Kazuki Y . Recurrent micronucleation through cell cycle progression in the presence of microtubule inhibitors. Cell Struct Funct. 2015; 40(1):51-9. DOI: 10.1247/csf.14005. View

13.

Nakamura T, Peng K, Harvey M, Greiner S, Lorimer I, James C . Rescue and propagation of fully retargeted oncolytic measles viruses. Nat Biotechnol. 2005; 23(2):209-14. DOI: 10.1038/nbt1060. View

14.

de Jong G, Telenius A, Vanderbyl S, Meitz A, Drayer J . Efficient in-vitro transfer of a 60-Mb mammalian artificial chromosome into murine and hamster cells using cationic lipids and dendrimers. Chromosome Res. 2001; 9(6):475-85. DOI: 10.1023/a:1011680529073. View

15.

Upender M, Habermann J, McShane L, Korn E, Barrett J, Difilippantonio M . Chromosome transfer induced aneuploidy results in complex dysregulation of the cellular transcriptome in immortalized and cancer cells. Cancer Res. 2004; 64(19):6941-9. PMC: 4772432. DOI: 10.1158/0008-5472.CAN-04-0474. View

16.

Suzuki N, Itou T, Hasegawa Y, Okazaki T, Ikeno M . Cell to cell transfer of the chromatin-packaged human beta-globin gene cluster. Nucleic Acids Res. 2009; 38(5):e33. PMC: 2836578. DOI: 10.1093/nar/gkp1168. View

17.

Hoshiya H, Kazuki Y, Abe S, Takiguchi M, Kajitani N, Watanabe Y . A highly stable and nonintegrated human artificial chromosome (HAC) containing the 2.4 Mb entire human dystrophin gene. Mol Ther. 2008; 17(2):309-17. PMC: 2835068. DOI: 10.1038/mt.2008.253. View

18.

Ayabe F, Katoh M, Inoue T, Kouprina N, Larionov V, Oshimura M . A novel expression system for genomic DNA loci using a human artificial chromosome vector with transformation-associated recombination cloning. J Hum Genet. 2005; 50(11):592-599. DOI: 10.1007/s10038-005-0300-6. View

19.

Kazuki Y, Kobayashi K, Aueviriyavit S, Oshima T, Kuroiwa Y, Tsukazaki Y . Trans-chromosomic mice containing a human CYP3A cluster for prediction of xenobiotic metabolism in humans. Hum Mol Genet. 2012; 22(3):578-92. DOI: 10.1093/hmg/dds468. View

20.

Nishimoto A, Miura N, Horikawa I, Kugoh H, Murakami Y, Hirohashi S . Functional evidence for a telomerase repressor gene on human chromosome 10p15.1. Oncogene. 2001; 20(7):828-35. DOI: 10.1038/sj.onc.1204165. View